Japanese Pharmaceuticals & Biotech Healthy potentially undervalued

Otsuka Holdings

Market Cap: JP¥5.7t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Kissei Pharmaceutical

Market Cap: JP¥188.2b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Daiichi Sankyo Company

Market Cap: JP¥5.1t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Astellas Pharma

Market Cap: JP¥4.4t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

Shionogi

Market Cap: JP¥2.6t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Sumitomo Pharma

Market Cap: JP¥796.4b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Santen Pharmaceutical

Market Cap: JP¥535.0b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Tsumura

Market Cap: JP¥274.9b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

PeptiDream

Market Cap: JP¥145.4b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.